4.7 Article

Z-scores for comparative analyses of spermatogonial numbers throughout human development

Journal

FERTILITY AND STERILITY
Volume 116, Issue 3, Pages 713-720

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2021.04.019

Keywords

Klinefelter syndrome; male fertility preservation; spermatogonia; cancer; Z-score

Funding

  1. Swedish Childhood Cancer Foundation [PR2019-0123, TJ2020-0023, PR2015-0073, TJ2015-0046]
  2. Finnish Cancer Society
  3. Finnish Foundation for Pediatric Research
  4. Swedish Research Council [2018-03094, 2016-01296]
  5. German Research Foundation [CRU326]
  6. Chinese Scholarship Council
  7. Birgitta and Carl-Axel Rydbeck's Research Grant for Paediatric Research [2020-00348, 2020-00335]

Ask authors/readers for more resources

This study utilized quantitative histologic data on human spermatogonial numbers to evaluate the effects on fertility index by creating Z-scores compared to reference means. The results showed that Z-scores for S/T values differed significantly between untreated samples, samples treated with nonalkylating agents, samples exposed to alkylating agents, and patients with Klinefelter syndrome.
Objective: To normalize age-dependent effects on standardized measures of spermatogonial quantity such as the number of spermatogonia per tubular cross-section (S/T) or fertility index. Design: Published quantitative histologic data on human spermatogonial numbers were used to create Z-scores for reference means and tested on archived testicular tissue samples. Setting: Retrospective cohort study. Patient(s): The sample cohort comprised testicular samples from 24 boys with cancer diagnosis and 10 with Klinefelter syndrome, as part of the fertility preservation programs NORDFERTIL and Androprotect, as well as archived histologic samples from 35 prepubertal boys with acute lymphoblastic leukemia and 20 testicular biobank samples. Intervention(s): None. Main Outcome Measure(s): Z-score values for S/T and fertility index on the basis of morphology and germ cell-specific markers (MAGEA4 and/or DDX4) were calculated, and the impact of cancer therapy exposure and genetic disorders on Z-score values was evaluated. Result(s): The Z-scores for S/T values in the nontreated samples (-2.08 +/- 2.20, n = 28) and samples treated with nonalkylating agents (-1.90 +/- 2.60, n = 25) were comparable within +/- 3 standard deviations of the reference mean value but differed significantly from samples exposed to alkylating agents (-12.14 +/- 9.20, n = 22) and from patients with Klinefelter syndrome (-11.56 +/- 4.89, n = 8). The Z-scores for S/T were correlated with increasing cumulative exposure to alkylating agents (r = -0.7020). Conclusion(s): The Z-score values for S/T allow for the quantification of genetic and cancer treatment-related effects on testicular tissue stored for fertility preservation, facilitating their use for patient counseling. (C) 2021 by American Society for Reproductive Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available